Price
Frequently asked questions
What is BICO Group's market capitalization?
What is the Earnings Per Share (EPS) for BICO Group?
What are the analyst ratings and target price for BICO Group's stock?
What is BICO Group's revenue over the trailing twelve months?
What is the EBITDA for BICO Group?
What is the free cash flow of BICO Group?
What is the 5-year beta of BICO Group's stock?
How many employees does BICO Group have, and what sector and industry does it belong to?
What is the free float of BICO Group's shares?
Financials
Market Cap
$216.46M5Y beta
1.91EPS (TTM)
-$1.376Free Float
43.94MRevenue (TTM)
$203.88MEBITDA (TTM)
$37.07MFree Cashflow (TTM)
-$3.24MPricing
Analyst Ratings
The price target is $9.957 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
828
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker